C - Chemistry – Metallurgy – 07 – H
Patent
C - Chemistry, Metallurgy
07
H
C07H 19/16 (2006.01) A61K 31/7076 (2006.01) A61P 9/00 (2006.01)
Patent
CA 2394861
N6 heterocyclic 8 modified adenosine derivatives that are selective, partial or full adenosine A1 receptor partial or full agonists, and as such, are useful for modifying cardiac activity, modifying adipocyte function, treating central nervous system disorders, and treating diabetic disorders and obesity in mammals, and especially in humans.
L'invention concerne des dérivés d'adénosine N<6> hétérocyclique modifiés en position 8, étant sélectivement des agonistes partiels ou entiers du récepteur A1 partiel ou entier de l'adénosine et, en tant que tels, sont utiles pour modifier l'activité cardiaque, la fonction de l'adipocyte, et pour traiter les troubles du système nerveux central, les troubles liés au diabète et l'obésité chez les mammifères et notamment chez l'homme.
Belardinelli Luiz
Ibrahim Prahba N.
Palle Venkata P.
Zablocki Jeff A.
Cv Therapeutics Inc.
Mbm Intellectual Property Law Llp
LandOfFree
N6 heterocyclic 8-modified adenosine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N6 heterocyclic 8-modified adenosine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N6 heterocyclic 8-modified adenosine derivatives will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1771518